CN102458419A - 组合物用于治疗粘膜炎的用途 - Google Patents

组合物用于治疗粘膜炎的用途 Download PDF

Info

Publication number
CN102458419A
CN102458419A CN2010800254173A CN201080025417A CN102458419A CN 102458419 A CN102458419 A CN 102458419A CN 2010800254173 A CN2010800254173 A CN 2010800254173A CN 201080025417 A CN201080025417 A CN 201080025417A CN 102458419 A CN102458419 A CN 102458419A
Authority
CN
China
Prior art keywords
compositions
chitosan
scope
mucositis
electronegative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800254173A
Other languages
English (en)
Chinese (zh)
Inventor
拉斯·阿道夫森
奥利·拉姆
安德斯·韦斯特马克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EXTHERA AB
Original Assignee
EXTHERA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EXTHERA AB filed Critical EXTHERA AB
Publication of CN102458419A publication Critical patent/CN102458419A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN2010800254173A 2009-06-10 2010-06-10 组合物用于治疗粘膜炎的用途 Pending CN102458419A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0950441 2009-06-10
SE0950441-6 2009-06-10
PCT/SE2010/050650 WO2010144044A1 (en) 2009-06-10 2010-06-10 Use of a composition for the treatment of mucositis

Publications (1)

Publication Number Publication Date
CN102458419A true CN102458419A (zh) 2012-05-16

Family

ID=43309105

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800254173A Pending CN102458419A (zh) 2009-06-10 2010-06-10 组合物用于治疗粘膜炎的用途

Country Status (9)

Country Link
US (1) US8906883B2 (cg-RX-API-DMAC7.html)
EP (1) EP2440216A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012529506A (cg-RX-API-DMAC7.html)
CN (1) CN102458419A (cg-RX-API-DMAC7.html)
AU (1) AU2010259284A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1009741A2 (cg-RX-API-DMAC7.html)
CA (1) CA2763092A1 (cg-RX-API-DMAC7.html)
RU (1) RU2011152518A (cg-RX-API-DMAC7.html)
WO (1) WO2010144044A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164430A (zh) * 2018-06-03 2021-07-23 格莱科米拉治疗公司 用于在暴露于电离辐射和/或化学疗法之后预防严重健康后果和/或组织损伤的方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2773017T3 (es) 2010-04-06 2020-07-09 Synedgen Inc Derivados de quitosano para el tratamiento de mucositis o ulceración
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
WO2015022907A1 (ja) * 2013-08-13 2015-02-19 生化学工業株式会社 カチオン化キトサンを含有する医薬
US20160287626A1 (en) * 2013-10-22 2016-10-06 Cantex Pharmaceuticals, Inc. Methods of treating and preventing radiation damage
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2019211483A1 (en) * 2018-05-04 2019-11-07 Bonoss Medical Aktiebolag A composition for reduction of scar formation
WO2021216494A1 (en) * 2020-04-24 2021-10-28 Intact Therapeutics, Inc. Compositions and methods for treatment of gastrointestinal bleeding
EP3981505B1 (en) * 2020-10-12 2024-11-27 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
SE545090C2 (en) * 2021-03-17 2023-03-28 Labrida As A hydrogel comprising chitosan for use in prevention and treatment of periodontal and peri-implant disease
WO2023044132A2 (en) * 2021-09-17 2023-03-23 Shawn Walker Use of chitosan complexes or compositions to reduce infiltration of environmental factors into the brain

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1227493A (zh) * 1996-08-06 1999-09-01 梅迪卡布公司 肝素或硫酸乙酰肝素与脱乙酰壳多糖结合用于预防或治疗由疱疹病毒引起的感染
CN1627948A (zh) * 2002-04-24 2005-06-15 麦迪卡博公司 治疗炎症性肠病的组合物和试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402531L (sv) * 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
SE9402529D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Anti-adherensmedel
DK1997478T3 (da) * 2001-02-15 2013-12-09 Access Pharma Inc Flydende formuleringer til forebyggelse og behandling af slimhindesygdomme og -lidelser
AU2002249046A1 (en) * 2001-04-23 2002-11-05 Nucryst Pharmaceuticals Corp. Lubricious coatings for substrates
WO2004032843A2 (en) * 2002-10-07 2004-04-22 Orapharma, Inc. Mucoadhesive tetracycline formulations
US20060058390A1 (en) * 2004-09-14 2006-03-16 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
EP1838335A1 (en) 2005-01-19 2007-10-03 Bonoss Medical AB Growth factor composition
DE102006024831B4 (de) 2006-05-24 2008-03-27 Heraeus Quarzglas Gmbh & Co. Kg Verfahren zur Herstellung eines Halbzeugs aus synthetischem Quarzglas
WO2008060764A2 (en) 2006-10-05 2008-05-22 Drugtech Corporation Topical therapies for oral mucositis and other conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1227493A (zh) * 1996-08-06 1999-09-01 梅迪卡布公司 肝素或硫酸乙酰肝素与脱乙酰壳多糖结合用于预防或治疗由疱疹病毒引起的感染
CN1627948A (zh) * 2002-04-24 2005-06-15 麦迪卡博公司 治疗炎症性肠病的组合物和试剂盒

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
托马斯: "《临床实验诊断学-实验结果的应用和评估》", 31 May 2004, 上海科学技术出版社, article "单纯疱疹病毒(HSV)1型", pages: 1236 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164430A (zh) * 2018-06-03 2021-07-23 格莱科米拉治疗公司 用于在暴露于电离辐射和/或化学疗法之后预防严重健康后果和/或组织损伤的方法

Also Published As

Publication number Publication date
RU2011152518A (ru) 2013-07-20
EP2440216A4 (en) 2013-09-11
WO2010144044A1 (en) 2010-12-16
CA2763092A1 (en) 2010-12-16
US8906883B2 (en) 2014-12-09
EP2440216A1 (en) 2012-04-18
JP2012529506A (ja) 2012-11-22
AU2010259284A1 (en) 2011-12-15
US20120077773A1 (en) 2012-03-29
BRPI1009741A2 (pt) 2016-03-15

Similar Documents

Publication Publication Date Title
US8906883B2 (en) Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
JP4354528B2 (ja) 間質性膀胱炎の治療へのヒアルロン酸の使用
AU753124B2 (en) Dextran formulations and method for treatment of inflammatory joint disorders
US6828308B2 (en) Compositions and methods for the treatment or prevention of inflammation
KR100761051B1 (ko) 점막염, 구내염 및 베체트 증후군 치료용 약학적 조성물
ES2688971T3 (es) Uso de oligouronatos
JP2002511057A (ja) 局所薬剤製剤
EP2034956B2 (en) Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
KR20040089628A (ko) 생체내에서 상전이하는 액상 매트릭스 및 액상 경구 제제
US20020176892A1 (en) Topical drug preparations
EP1865920A1 (en) Prevention and treatment of radiation dermatitis
US11826380B2 (en) Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
ES2219070T3 (es) Uso de acido haluronico en el tratamiento de la cistitis por radiacion.
JP6595717B2 (ja) 骨関節炎治療のための親水化されたスルファサラジンおよびヒアルロン酸を含む組成物およびその製造方法
US7141251B2 (en) Pharmacologically active strong acid solutions
Mann et al. Pentazocine ulcers
WO2015023226A1 (en) Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion
WO2023177835A1 (en) Treatment of uterine fibroids
Al-Khuwaitir et al. Chronic granulomatous disease with recurrent hepatic abscesses in an adult
MXPA97006182A (es) Uso de acido hialuronico para el tratamiento de cistitis intersticial

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120516